If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCRF.L Regulatory News (SCRF)

  • There is currently no data for SCRF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Circular and Notice of EGM

6 Mar 2023 07:00

RNS Number : 9006R
SME Credit Realisation Fund Limited
06 March 2023
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK MARKET ABUSE REGULATION.

 

 

******

6 March 2023

SME Credit Realisation Fund Limited

 

(the "Company")

 

PUBLICATION AND POSTING OF CIRCULAR

 

AND

 

TIMETABLE FOR SUSPENSION AND CANCELLATION OF THE COMPANY'S LISTING AND TRADING AND VOLUNTARY WINDING-UP OF THE COMPANY

 

Further to the announcement made on 18 January 2023, the Company announces the publication of a circular (the "Circular") and notice of extraordinary general meeting (the "EGM"), which has been posted to Shareholders for the purpose of proposing a vote on the liquidation of the Company (the "Proposals"). The detailed reasons for and background to the Proposals are set out in the Circular. The Circular also contains details of the timetable for the suspension and cancellation of the Company's listing and trading of the Shares on the Main Market. In order for the Proposals to become effective Resolution 1 must be approved by a majority of not less than seventy-five per cent. of the votes cast by Shareholders who, being entitled to vote, are present in person or by proxy at the Extraordinary General Meeting while Resolutions 2 to 5 must be approved by a simple majority of votes cast by Shareholders who, being entitled to vote, are present in person or by proxy at the Extraordinary General Meeting.

 

The Circular will be available to download from the Company website (https://www.smecreditrealisation.com/) and National Storage Mechanism (https://data.fca.org.uk/#/nsm/nationalstoragemechanism) shortly.

 

The current timetable for the Proposals are as follows:

 

Record date for participation and voting at the Extraordinary General Meeting

11 a.m. on 22 March 2023

Latest time and date for receipt of Form of Proxy for the Extraordinary General Meeting*

11 a.m. on 22 March 2023

Closing of the Company's register and record date for participation in liquidation distributions

6.30 p.m. on 23 March 2023

Suspension of listing and trading of the Shares

7.30 a.m. on 24 March 2023

Extraordinary General Meeting

11 a.m. on 24 March 2023

Joint Liquidators appointed

 24 March 2023

Announcement of results of the Extraordinary General Meeting

24 March 2023

Cancellation of listing and trading of the Shares on the Main Market

8 a.m. on 27 March 2023

 

Each of the times and dates in the expected timetable of events may be extended or brought forward without notice. If any of the above times and/or dates change materially, the revised time(s) and/or date(s) will be notified to Shareholders by an announcement through an RIS provider. All references are to London time unless otherwise stated.

 

The Company's shares will be suspended from trading at 7:30 a.m. on 24 March 2023 in advance of the EGM. Conditional on the approval of Shareholders at the EGM, the Board proposes to appoint Andrea Frances Alice Harris and Benjamin Alexander Rhodes of Grant Thornton as Joint Liquidators of the Company (the "Joint Liquidators").

 

Immediately upon and with effect from the appointment of the Joint Liquidators at the GM, the powers of the Board will cease, the Joint Liquidators will wind up the affairs of the Company, and listing of the Ordinary Shares on the Official List and admission to trading of the Ordinary Shares on the Main Market will be cancelled with effect from 8.00 a.m. on 27 March 2023 following which the Company's shares will no longer be tradeable.

 

CONTACTS

Frédéric Hervouet, Chairman

+44 (0)77 81 159 007 fred_hervouet@hotmail.com

 

Secretary and Administrator

Sanne Group (Guernsey) Limited

+44 (0) 1481 739810

smecreditrealisation@sannegroup.com

   

Corporate Broker

Numis Securities

Nathan Brown

George Shiel

+44 (0) 207 260 1000

 

Investor Relations

IR@smecreditrealisation.com

 

Website

www.smecreditrealisation.com

 

The ISIN number of the Ordinary Shares is GG00BKQN9M74, the SEDOL code is BKQN9M7 and the TIDM is SCRF.

 

The LEI number of the Company is 549300ZQIYQVNIZGOW60. 

 

*****

 

ABOUT SME Credit Realisation Fund Limited

The Company is a registered closed-ended collective investment scheme registered pursuant to the Protection of Investors (Bailiwick of Guernsey) Law, 2020, as amended and the Registered Collective Investment Scheme Rules and Guidance, 2021 issued by the Guernsey Financial Services Commission (''GFSC''). 

 

*****

 

IMPORTANT NOTICES

 

This announcement contains "forward-looking" statements, beliefs or opinions. These forward-looking statements involve known and unknown risks and uncertainties, many of which are beyond the control of the Company and all of which are based on its directors' current beliefs and expectations about future events. Forward-looking statements are sometimes identified by the use of forward-looking terminology such as "believes", "expects", "may", "will", "could", "should", "shall", "risk", "intends", "estimates", "aims", "plans", "predicts", "projects", "continues", "assumes", "positioned" or "anticipates" or the negative thereof, other variations thereon or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events, assumptions or intentions. These forward-looking statements include all matters that are not historical facts. Forward-looking statements may and often do differ materially from actual results. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the Board or the Company with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business concerning, amongst other things, the financial performance, liquidity, prospects, growth and strategies of the Company. These forward-looking statements and other statements contained in this announcement regarding matters that are not historical facts involve predictions. No assurance can be given that such future results will be achieved; actual events or results may differ materially as a result of risks and uncertainties facing the Company. Such risks and uncertainties could cause actual results to vary materially from the future results indicated, expressed or implied in such forward-looking statements. The forward-looking statements contained in this announcement speak only as of the date of this announcement. Nothing in this announcement is, or should be relied on as, a promise or representation as to the future. The Company disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in its expectations or any change in events, conditions or circumstances on which such statements are based unless required to do so by applicable law, the Prospectus Rules, the Listing Rules or the Disclosure Rules and Transparency Rules of the FCA. No statement in this announcement is intended as a forecast or profit estimate.

 

Neither this announcement nor any copy of it may be made or transmitted into the United States of America (including its territories or possessions, any state of the United States of America and the District of Columbia) (the "United States"), or distributed, directly or indirectly, in the United States or to US Persons (as such term is defined in Regulation S under the US Securities Act of 1933, as amended (the "Securities Act"). Neither this announcement nor any copy of it may be taken or transmitted directly or indirectly into Australia, Canada, Japan or South Africa or to any persons in any of those jurisdictions, except in compliance with applicable securities laws. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese or South African securities laws. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions. This announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for securities in the United States, Australia, Canada, Japan or South Africa or in any jurisdiction to whom or in which such offer or solicitation is unlawful.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIRUSSBROKUORRR
Date   Source Headline
27th Oct 20204:41 pmRNSSecond Price Monitoring Extn
27th Oct 20204:35 pmRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSNAV and Return of Capital
1st Oct 20209:34 amRNSTotal Voting Rights
16th Sep 202010:55 amRNSResult of AGM
8th Sep 20204:41 pmRNSSecond Price Monitoring Extn
8th Sep 20204:36 pmRNSPrice Monitoring Extension
2nd Sep 202010:26 amRNSTotal Voting Rights
26th Aug 20204:15 pmRNSNotice of AGM
3rd Aug 20204:42 pmRNSTotal Voting Rights
29th Jul 20204:06 pmRNSTotal Voting Rights
28th Jul 20206:19 pmRNSDirector/PDMR Shareholding
28th Jul 20206:18 pmRNSDirector/PDMR Shareholding
28th Jul 20206:18 pmRNSDirector/PDMR Shareholding
28th Jul 202010:52 amRNSAnnual Financial Report
21st Jul 20207:00 amRNSNAV and Return of Capital
1st Jul 20204:38 pmRNSTotal Voting Rights
2nd Jun 20201:00 pmRNSNet Asset Value(s)
1st Jun 20205:31 pmRNSTotal Voting Rights
19th May 20204:41 pmRNSSecond Price Monitoring Extn
19th May 20204:36 pmRNSPrice Monitoring Extension
1st May 20202:01 pmRNSTotal Voting Rights
21st Apr 20202:48 pmRNSTotal Voting Rights
14th Apr 20204:55 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSDividend Declaration
3rd Apr 20207:00 amRNSCompany Update
2nd Apr 20207:00 amRNSTransaction in Own Shares
1st Apr 20201:52 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSTransaction in Own Shares
31st Mar 20207:00 amRNSTransaction in Own Shares
30th Mar 20207:00 amRNSTransaction in Own Shares
27th Mar 20207:00 amRNSTransaction in Own Shares
25th Mar 20202:31 pmRNSTransaction in Own Shares
25th Mar 20207:00 amRNSTransaction in Own Shares
24th Mar 20207:00 amRNSTransaction in Own Shares
23rd Mar 20207:00 amRNSTransaction in Own Shares
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
18th Mar 20204:34 pmRNSTransaction in Own Shares
17th Mar 20203:52 pmRNSTransaction in Own Shares
17th Mar 20207:00 amRNSTransaction in Own Shares
12th Mar 202011:58 amRNSTransaction in Own Shares
10th Mar 20207:00 amRNSTransaction in Own Shares
2nd Mar 20202:07 pmRNSTotal Voting Rights
26th Feb 20207:00 amRNSTransaction in Own Shares
7th Feb 20203:32 pmRNSCompany Update
3rd Feb 20207:00 amRNSTotal Voting Rights
29th Jan 202012:56 pmRNSHolding(s) in Company
27th Jan 20205:20 pmRNSTotal Voting Rights
23rd Jan 20204:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.